NanoViricides CEO to Speak at NanoBio 2009

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), a development stage company that is creating special purpose nanomaterials for viral therapy, announced today that its CEO, Dr. Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on "Nanoparticle Formulation: principles and applications", at the 3rd International Congress of NanoBiotechnology + NanoMedicine (NanoBio 2009) to be held in San Francisco on June 22-24, 2009. The website for the event is The conference is sponsored by, among others, The National Cancer Institute, the National Institute of Standards and Technology, the Lawrence Berkeley National Laboratory and Stanford University.

Dr Seymour plans to discuss the nature of the Company’s nanoviricide™ drug technology and platform as well as results of various laboratory and animal studies against different viruses. Dr. Seymour will summarize the Company’s successes against multiple types of influenza viruses including different H5N1 bird flu viruses and H1N1 virus similar to the current pandemic-causing H1N1. He will also talk about the Company’s successes against HIV, adenoviral epidemic keratoconjunctivitis (EKC), Ebola and Rabies. In addition to these programs, the Company is also developing nanoviricide drugs against dengue viruses. His talk is scheduled for Tuesday, the 23rd June, 2009. The workshop takes place in two sessions on Monday, the 22nd.

NanoViricides, Inc. ( is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal Influenza, HIV, EKC, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NanoViricides, Inc. (2019, March 19). NanoViricides CEO to Speak at NanoBio 2009. AZoNano. Retrieved on April 23, 2024 from

  • MLA

    NanoViricides, Inc. "NanoViricides CEO to Speak at NanoBio 2009". AZoNano. 23 April 2024. <>.

  • Chicago

    NanoViricides, Inc. "NanoViricides CEO to Speak at NanoBio 2009". AZoNano. (accessed April 23, 2024).

  • Harvard

    NanoViricides, Inc. 2019. NanoViricides CEO to Speak at NanoBio 2009. AZoNano, viewed 23 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.